Nephrotic syndrome following topically applied sulfadiazine silver therapy.
D000287:Administration, Topical; D000368:Aged; D002057:Burns, Chemical / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D007668:Kidney / Q000473:pathology; D008297:Male; D009404:Nephrotic Syndrome / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology; D011241:Prednisone / Q000627:therapeutic use; D013411:Sulfadiazine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
D013411:Sulfadiazine; D003520:Cyclophosphamide; D011241:Prednisone